nach oben

Endocrine

Erschienen in:

01.08.2014 | Original Article

Common genetic variation in sFRP5 is associated with fat distribution in men

verfasst von: J. K. Van Camp, S. Beckers, D. Zegers, A. Verrijken, L. F. Van Gaal, W. Van Hul

Erschienen in: Endocrine | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Considering the role of sFRP5 in Wnt signalling, an important group of pathways regulating adipogenesis and inflammation, we performed a genetic association study on sFRP5 polymorphisms in a population of obese and lean individuals. Using information from the HapMap, two tagSNPs were identified in the sFRP5 gene region and genotyped on a population of 1,014 obese, non-diabetic individuals and 606 lean controls. We performed logistic and linear regression analysis including a wide variety of obesity parameters (BMI, waist circumference, height, WHR, fat mass, fat mass percentage and visceral, subcutaneous and total abdominal fat), in addition to OGTT and HOMA-IR values. We were able to show a significant association of sFRP5 with both total abdominal and subcutaneous fat. The association signal was only seen in obese males, and in this population, the minor allele of rs7072751 explains 1.8 % of variance in total abdominal fat. In addition, we saw a trend towards an association of rs10748709 with glucose metabolism. Although further research is necessary, we can conclude that sFRP5 is a significant regulator of fat development and distribution in obese males. We postulate that altered transcription factor binding on the rs7072751 surrounding sequence might play a role in the associations we found with both total abdominal and subcutaneous fat. In addition, although no conclusive evidence was found, our results indicate that sFRP5 genetic variation may affect glucose metabolism and it would be interesting to investigate this further.

L.F. Van Gaal, I.L. Mertens, C.E. De Block, Mechanisms linking obesity with cardiovascular disease. Nature 444(7121), 875–880 (2006)PubMedCrossRef

G.A. Colditz et al., Weight gain as a risk factor for clinical diabetes mellitus in women. Ann. Intern. Med. 122(7), 481–486 (1995)PubMedCrossRef

A. Bergstrom et al., Overweight as an avoidable cause of cancer in Europe. Int. J. Cancer 91(3), 421–430 (2001)PubMedCrossRef

E.E. Kershaw, J.S. Flier, Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89(6), 2548–2556 (2004)PubMedCrossRef

N. Ouchi et al., Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329(5990), 454–457 (2010)PubMedCentralPubMedCrossRef

Y. Kawano, R. Kypta, Secreted antagonists of the Wnt signalling pathway. J. Cell Sci. 116(Pt 13), 2627–2634 (2003)PubMedCrossRef

P.W. Finch et al., Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc. Natl. Acad. Sci. USA 94(13), 6770–6775 (1997)PubMedCentralPubMedCrossRef

S. Kang et al., Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 282(19), 14515–14524 (2007)PubMedCrossRef

P. Bhanot et al., A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 382(6588), 225–230 (1996)PubMedCrossRef

10.

A. Bejsovec, Wnt signaling: an embarrassment of receptors. Curr. Biol. 10(24), R919–R922 (2000)PubMedCrossRef

11.

J. Papkoff et al., Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes. Mol. Cell. Biol. 16(5), 2128–2134 (1996)PubMedCentralPubMed

12.

H. Clevers, M. van de Wetering, TCF/LEF factor earn their wings. Trends Genet. 13(12), 485–489 (1997)PubMedCrossRef

13.

M. Kawai et al., Wnt/Lrp/beta-catenin signaling suppresses adipogenesis by inhibiting mutual activation of PPARgamma and C/EBPalpha. Biochem. Biophys. Res. Commun. 363(2), 276–282 (2007)PubMedCrossRef

14.

K.A. Longo et al., Wnt10b inhibits development of white and brown adipose tissues. J. Biol. Chem. 279(34), 35503–35509 (2004)PubMedCrossRef

15.

C.N. Bennett et al., Regulation of Wnt signaling during adipogenesis. J. Biol. Chem. 277(34), 30998–31004 (2002)PubMedCrossRef

16.

J.A. Kennell, O.A. MacDougald, Wnt signaling inhibits adipogenesis through beta-catenin-dependent and -independent mechanisms. J. Biol. Chem. 280(25), 24004–24010 (2005)PubMedCrossRef

17.

A. Ahumada et al., Signaling of rat Frizzled-2 through phosphodiesterase and cyclic GMP. Science 298(5600), 2006–2010 (2002)PubMedCrossRef

18.

A.D. Kohn, R.T. Moon, Wnt and calcium signaling: beta-catenin-independent pathways. Cell Calcium 38(3–4), 439–446 (2005)PubMedCrossRef

19.

L. Ma, H.Y. Wang, Mitogen-activated protein kinase p38 regulates the Wnt/cyclic GMP/Ca²⁺ non-canonical pathway. J. Biol. Chem. 282(39), 28980–28990 (2007)PubMedCrossRef

20.

K. Schlessinger, E.J. McManus, A. Hall, Cdc42 and noncanonical Wnt signal transduction pathways cooperate to promote cell polarity. J. Cell Biol. 178(3), 355–361 (2007)PubMedCentralPubMedCrossRef

21.

R. Sugimura, L. Li, Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases. Birth Defects Res. C Embryo Today 90(4), 243–256 (2010)PubMedCrossRef

22.

J. Hirosumi et al., A central role for JNK in obesity and insulin resistance. Nature 420(6913), 333–336 (2002)PubMedCrossRef

23.

G. Solinas et al., JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab. 6(5), 386–397 (2007)PubMedCrossRef

24.

W. Hu et al., Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans. J. Clin. Endocrinol. Metab. 98(1), 290–298 (2013)PubMedCrossRef

25.

Z. Hu, H. Deng, H. Qu, Plasma SFRP5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance. Diabetes Res. Clin. Pract. 99, 391–395 (2013)PubMedCrossRef

26.

H. Mori et al., Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition. J. Clin. Invest. 122(7), 2405–2416 (2012)PubMedCentralPubMedCrossRef

27.

F.R. Day, R.J. Loos, Developments in obesity genetics in the era of genome-wide association studies. J. Nutrigenet. Nutrigenom. 4(4), 222–238 (2011)CrossRef

28.

K. van der Kooy, J.C. Seidell, Techniques for the measurement of visceral fat: a practical guide. Int. J. Obes. Relat. Metab. Disord. 17(4), 187–196 (1993)PubMed

29.

H.C. Lukaski et al., Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am. J. Clin. Nutr. 41(4), 810–817 (1985)PubMed

30.

P. Deurenberg, J.A. Weststrate, J.G. Hautvast, Changes in fat-free mass during weight loss measured by bioelectrical impedance and by densitometry. Am. J. Clin. Nutr. 49(1), 33–36 (1989)PubMed

31.

D.R. Matthews et al., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7), 412–419 (1985)PubMedCrossRef

32.

S.A. Miller, D.D. Dykes, H.F. Polesky, A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16(3), 1215 (1988)PubMedCentralPubMedCrossRef

33.

International HapMap Consorium, The International HapMap Project. Nature 426(6968), 789–796 (2003)CrossRef

34.

The International HapMap Project (2011), http://hapmap.ncbi.nlm.nih.gov/thehapmap.html.en. Accessed 06 Jun 2013

35.

P.I. de Bakker et al., Efficiency and power in genetic association studies. Nat. Genet. 37(11), 1217–1223 (2005)PubMedCrossRef

36.

S. Purcell et al., PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81(3), 559–575 (2007)PubMedCentralPubMedCrossRef

37.

J. Ott, Documentation to LINKAGE UTILITY programs (2011), http://linkage.rockefeller.edu/ott/linkutil.htm. Accessed 10 Feb 2011

38.

W. Gauderman, J. Morrison, Gene × environment, gene × gene interaction home page (2009), http://hydra.usc.edu/gxe/. Accessed 10 Feb 2011

39.

T. Heinemeyer et al., Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 26(1), 362–367 (1998)PubMedCentralPubMedCrossRef

40.

D.M. Schulte et al., Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects. PLoS ONE 7(2), e32437 (2012)PubMedCentralPubMedCrossRef

41.

C. Lv et al., Sfrp5 expression and secretion in adipocyte are upregulated during the differentiation and are negatively correlated with insulin resistance. Cell Biol. Int. 36, 851–855 (2012)PubMedCrossRef

42.

E.K. Speliotes et al., Association analyses of 249, 796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 42(11), 937–948 (2010)PubMedCentralPubMedCrossRef

43.

G. Thorleifsson et al., Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat. Genet. 41(1), 18–24 (2009)PubMedCrossRef

44.

I.M. Heid et al., Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat. Genet. 42(11), 949–960 (2010)PubMedCentralPubMedCrossRef

45.

A. Scherag et al., Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german study groups. PLoS Genet. 6(4), e1000916 (2010)PubMedCentralPubMedCrossRef

46.

O. Komine et al., The Runx1 transcription factor inhibits the differentiation of naive CD4⁺ T cells into the Th2 lineage by repressing GATA3 expression. J. Exp. Med. 198(1), 51–61 (2003)PubMedCentralPubMedCrossRef

47.

S. Lemieux et al., Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am. J. Clin. Nutr. 58(4), 463–467 (1993)PubMed

48.

S. Cha, H. Yu, J.Y. Kim, Bone mineral density-associated polymorphisms are associated with obesity-related traits in Korean adults in a sex-dependent manner. PLoS ONE 7(12), e53013 (2012)PubMedCentralPubMedCrossRef

Titel: Common genetic variation in sFRP5 is associated with fat distribution in men
verfasst von: J. K. Van Camp
S. Beckers
D. Zegers
A. Verrijken
L. F. Van Gaal
W. Van Hul
Publikationsdatum: 01.08.2014
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 3/2014
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-013-0088-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2014

Meta-analysis of methylcobalamin alone and in combination with prostaglandin E1 in the treatment of diabetic peripheral neuropathy

Contrast agent suppresses endothelium-dependent arterial dilation after digital subtraction angiography procedure in patients with diabetic foot

Interleukin-21 is associated with disease activity in patients with Graves’ disease

Changes of gastric aromatase and portal venous 17β-estradiol during the postnatal development and estrus cycle in female rats

Transcription factor Ets-1 inhibits glucose-stimulated insulin secretion of pancreatic β-cells partly through up-regulation of COX-2 gene expression